Australia In Vitro Diagnostics Market Outlook to 2025 – Cardiac Disease, Clinical Chemistry, Hematological Disorders and Others.

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

$5995
Buy Report

Published: April 30, 2020 Report Code: GDMEMC0522DB-ST

Select Item

GlobalData’s “Australia In Vitro Diagnostics Market Outlook to 2025” is a comprehensive databook report, covering key market data on the Australia In Vitro Diagnostics market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments – Cardiac Disease, Clinical Chemistry, Hematological Disorders, Hormonal Disorders, Infectious Disease, IVD Analyzers and Reagents, Metabolic Disorder, Oncology and Women's Health.

The Australia In Vitro Diagnostics Market report provides key information and data on:
• Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2015 to 2025.
• 2018 company share and distribution share data for In Vitro Diagnostics Market.
• Global corporate-level profiles of key companies operating within the Australia In Vitro Diagnostics Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.

Scope

Australia In Vitro Diagnostics Tests is segmented as follows:

• Cardiac Disease

• Clinical Chemistry

• Hematological Disorders

• Hormonal Disorder

• Infectious Disease

• IVD Analyzers and Reagents

• Metabolic Disorder

• Oncology

• Women's Health

Reasons to Buy

Key Reasons to Purchase – The Australia In Vitro Diagnostics Market report helps you to develop:

• Business strategies by identifying the key market segments poised for strong growth in the future.

• Market-entry and market expansion strategies.

• Design competition strategies by identifying who-stands-where in the market.

• Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.

• Understand the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.

Key companies covered in the “Australia In Vitro Diagnostics Market Outlook to 2025” report:
• F. Hoffmann-La Roche Ltd
• Abbott Laboratories
• Siemens Healthineers AG

Table

1.1 List of Tables

Table 1: In Vitro Diagnostics Market, Australia, Revenue ($m), USD Constant, 2015-2025 48

Table 2: In Vitro Diagnostics Market, Australia, Category Contribution by Revenue ($m), 2018 51

Table 3: In Vitro Diagnostics Market, Australia, Revenue ($m), USD Constant, Historic, 2015-2020 53

Table 4: In Vitro Diagnostics Market, Australia, Revenue ($m), USD Constant, Forecast, 2021-2025 54

Table 5: In Vitro Diagnostics Market, Australia, Volume (Units), 2015-2025 56

Table 6: In Vitro Diagnostics Market, Australia, Volume (Units), Historic, 2015-2020 58

Table 7: In Vitro Diagnostics Market, Australia, Volume (Units), Forecast, 2021-2025 59

Table 8: In Vitro Diagnostics Market, Australia, Company Share by Revenue ($m), USD Constant, 2018 61

Table 9: Cardiac Disease Market, Australia, Revenue ($m), USD Constant, 2015-2020 63

Table 10: Cardiac Disease Market, Australia, Revenue ($m), USD Constant, 2021-2025 63

Table 11: Cardiac Marker Tests Market, Australia, Revenue ($m), USD Constant, 2015-2020 65

Table 12: Cardiac Marker Tests Market, Australia, Revenue ($m), USD Constant, 2021-2025 66

Table 13: Cardiac Disease Market, Australia, Volume (Units), 2015-2020 68

Table 14: Cardiac Disease Market, Australia, Volume (Units), 2021-2025 68

Table 15: Cardiac Marker Tests Market, Australia, Volume (Units), 2015-2020 70

Table 16: Cardiac Marker Tests Market, Australia, Volume (Units), 2021-2025 71

Table 17: Cardiac Disease Market, Australia, Average Price ($), 2015-2020 72

Table 18: Cardiac Disease Market, Australia, Average Price ($), 2021-2025 73

Table 19: Cardiac Disease Market, Australia, Distribution Share by Revenue ($m), USD Constant, 2018 74

Table 20: Cardiac Disease Market, Australia, Company Share by Revenue ($m), USD Constant, 2018 76

Table 21: Clinical Chemistry Market, Australia, Revenue ($m), USD Constant, 2015-2020 78

Table 22: Clinical Chemistry Market, Australia, Revenue ($m), USD Constant, 2021-2025 78

Table 23: Substrates Market, Australia, Revenue ($m), USD Constant, 2015-2020 80

Table 24: Substrates Market, Australia, Revenue ($m), USD Constant, 2021-2025 81

Table 25: Clinical Chemistry Market, Australia, Volume (Units), 2015-2020 83

Table 26: Clinical Chemistry Market, Australia, Volume (Units), 2021-2025 83

Table 27: Substrates Market, Australia, Volume (Units), 2015-2020 85

Table 28: Substrates Market, Australia, Volume (Units), 2021-2025 86

Table 29: Clinical Chemistry Market, Australia, Average Price ($), 2015-2020 87

Table 30: Clinical Chemistry Market, Australia, Average Price ($), 2021-2025 88

Table 31: Clinical Chemistry Market, Australia, Distribution Share by Revenue ($m), USD Constant, 2018 89

Table 32: Clinical Chemistry Market, Australia, Company Share by Revenue ($m), USD Constant, 2018 90

Table 33: Hematological Disorders Market, Australia, Segment Contribution (%), 2018 92

Table 34: Hematological Disorders Market, Australia, Revenue ($m), USD Constant, 2015-2020 94

Table 35: Hematological Disorders Market, Australia, Revenue ($m), USD Constant, 2021-2025 94

Table 36: Hematology Tests Market, Australia, Revenue ($m), USD Constant, 2015-2020 96

Table 37: Hematology Tests Market, Australia, Revenue ($m), USD Constant, 2021-2025 97

Table 38: Hemostasis Tests Market, Australia, Revenue ($m), USD Constant, 2015-2020 99

Table 39: Hemostasis Tests Market, Australia, Revenue ($m), USD Constant, 2021-2025 100

Table 40: Hematological Disorders Market, Australia, Volume (Units), 2015-2020 102

Table 41: Hematological Disorders Market, Australia, Volume (Units), 2021-2025 102

Table 42: Hematology Tests Market, Australia, Volume (Units), 2015-2020 104

Table 43: Hematology Tests Market, Australia, Volume (Units), 2021-2025 105

Table 44: Hemostasis Tests Market, Australia, Volume (Units), 2015-2020 107

Table 45: Hemostasis Tests Market, Australia, Volume (Units), 2021-2025 108

Table 46: Hematological Disorders Market, Australia, Average Price ($), 2015-2020 109

Table 47: Hematological Disorders Market, Australia, Average Price ($), 2021-2025 111

Table 48: Hematological Disorders Market, Australia, Distribution Share by Revenue ($m), USD Constant, 2018 113

Table 49: Hematological Disorders Market, Australia, Company Share by Revenue ($m), USD Constant, 2018 115

Table 50: Hormonal Disorders Market, Australia, Revenue ($m), USD Constant, 2015-2020 117

Table 51: Hormonal Disorders Market, Australia, Revenue ($m), USD Constant, 2021-2025 117

Table 52: Thyroid Function Tests Market, Australia, Revenue ($m), USD Constant, 2015-2020 119

Table 53: Thyroid Function Tests Market, Australia, Revenue ($m), USD Constant, 2021-2025 120

Table 54: Hormonal Disorders Market, Australia, Volume (Units), 2015-2020 122

Table 55: Hormonal Disorders Market, Australia, Volume (Units), 2021-2025 122

Table 56: Thyroid Function Tests Market, Australia, Volume (Units), 2015-2020 124

Table 57: Thyroid Function Tests Market, Australia, Volume (Units), 2021-2025 125

Table 58: Hormonal Disorders Market, Australia, Average Price ($), 2015-2020 126

Table 59: Hormonal Disorders Market, Australia, Average Price ($), 2021-2025 127

Table 60: Hormonal Disorders Market, Australia, Distribution Share by Revenue ($m), USD Constant, 2018 128

Table 61: Hormonal Disorders Market, Australia, Company Share by Revenue ($m), USD Constant, 2018 130

Table 62: Infectious Disease Market, Australia, Segment Contribution (%), 2018 133

Table 63: Infectious Disease Market, Australia, Revenue ($m), USD Constant, 2015-2020 135

Table 64: Infectious Disease Market, Australia, Revenue ($m), USD Constant, 2021-2025 137

Table 65: Chlamydia Trachomatis Tests Market, Australia, Revenue ($m), USD Constant, 2015-2020 140

Table 66: Chlamydia Trachomatis Tests Market, Australia, Revenue ($m), USD Constant, 2021-2025 140

Table 67: Clostridium difficile Tests Market, Australia, Revenue ($m), USD Constant, 2015-2020 142

Table 68: Clostridium difficile Tests Market, Australia, Revenue ($m), USD Constant, 2021-2025 142

Table 69: Cytomegalovirus (CMV) Tests Market, Australia, Revenue ($m), USD Constant, 2015-2020 144

Table 70: Cytomegalovirus (CMV) Tests Market, Australia, Revenue ($m), USD Constant, 2021-2025 144

Table 71: Hepatitis Tests Market, Australia, Revenue ($m), USD Constant, 2015-2020 146

Table 72: Hepatitis Tests Market, Australia, Revenue ($m), USD Constant, 2021-2025 146

Table 73: Human Immunodeficiency Virus (HIV) Tests Market, Australia, Revenue ($m), USD Constant, 2015-2020 148

Table 74: Human Immunodeficiency Virus (HIV) Tests Market, Australia, Revenue ($m), USD Constant, 2021-2025 149

Table 75: Human Papilloma Virus (HPV) Tests Market, Australia, Revenue ($m), USD Constant, 2015-2020 151

Table 76: Human Papilloma Virus (HPV) Tests Market, Australia, Revenue ($m), USD Constant, 2021-2025 151

Table 77: Human T-Lymphotropic Virus (HTLV) Tests Market, Australia, Revenue ($m), USD Constant, 2015-2020 153

Table 78: Human T-Lymphotropic Virus (HTLV) Tests Market, Australia, Revenue ($m), USD Constant, 2021-2025 153

Table 79: Mycobacterium Tuberculosis Tests Market, Australia, Revenue ($m), USD Constant, 2015-2020 155

Table 80: Mycobacterium Tuberculosis Tests Market, Australia, Revenue ($m), USD Constant, 2021-2025 155

Table 81: Neisseria Gonorrhoeae Tests Market, Australia, Revenue ($m), USD Constant, 2015-2020 157

Table 82: Neisseria Gonorrhoeae Tests Market, Australia, Revenue ($m), USD Constant, 2021-2025 157

Table 83: Treponema pallidum Tests Market, Australia, Revenue ($m), USD Constant, 2015-2020 159

Table 84: Treponema pallidum Tests Market, Australia, Revenue ($m), USD Constant, 2021-2025 160

Table 85: Infectious Disease Market, Australia, Volume (Units), 2015-2020 162

Table 86: Infectious Disease Market, Australia, Volume (Units), 2021-2025 164

Table 87: Chlamydia Trachomatis Tests Market, Australia, Volume (Units), 2015-2020 167

Table 88: Chlamydia Trachomatis Tests Market, Australia, Volume (Units), 2021-2025 167

Table 89: Clostridium difficile Tests Market, Australia, Volume (Units), 2015-2020 169

Table 90: Clostridium difficile Tests Market, Australia, Volume (Units), 2021-2025 170

Table 91: Cytomegalovirus (CMV) Tests Market, Australia, Volume (Units), 2015-2020 172

Table 92: Cytomegalovirus (CMV) Tests Market, Australia, Volume (Units), 2021-2025 172

Table 93: Hepatitis Tests Market, Australia, Volume (Units), 2015-2020 174

Table 94: Hepatitis Tests Market, Australia, Volume (Units), 2021-2025 174

Table 95: Human Immunodeficiency Virus (HIV) Tests Market, Australia, Volume (Units), 2015-2020 176

Table 96: Human Immunodeficiency Virus (HIV) Tests Market, Australia, Volume (Units), 2021-2025 177

Table 97: Human Papilloma Virus (HPV) Tests Market, Australia, Volume (Units), 2015-2020 179

Table 98: Human Papilloma Virus (HPV) Tests Market, Australia, Volume (Units), 2021-2025 179

Table 99: Human T-Lymphotropic Virus (HTLV) Tests Market, Australia, Volume (Units), 2015-2020 181

Table 100: Human T-Lymphotropic Virus (HTLV) Tests Market, Australia, Volume (Units), 2021-2025 181

Table 101: Mycobacterium Tuberculosis Tests Market, Australia, Volume (Units), 2015-2020 183

Table 102: Mycobacterium Tuberculosis Tests Market, Australia, Volume (Units), 2021-2025 183

Table 103: Neisseria Gonorrhoeae Tests Market, Australia, Volume (Units), 2015-2020 185

Table 104: Neisseria Gonorrhoeae Tests Market, Australia, Volume (Units), 2021-2025 185

Table 105: Treponema pallidum Tests Market, Australia, Volume (Units), 2015-2020 187

Table 106: Treponema pallidum Tests Market, Australia, Volume (Units), 2021-2025 188

Table 107: Infectious Disease Market, Australia, Average Price ($), 2015-2020 189

Table 108: Infectious Disease Market, Australia, Average Price ($), 2021-2025 192

Table 109: Infectious Disease Market, Australia, Distribution Share by Revenue ($m), USD Constant, 2018 195

Table 110: Infectious Disease Market, Australia, Company Share by Revenue ($m), USD Constant, 2018 197

Table 111: IVD Analyzers and Reagents Market, Australia, Segment Contribution (%), 2018 199

Table 112: IVD Analyzers and Reagents Market, Australia, Revenue ($m), USD Constant, 2015-2020 201

Table 113: IVD Analyzers and Reagents Market, Australia, Revenue ($m), USD Constant, 2021-2025 202

Table 114: Clinical Chemistry Analyzers Market, Australia, Revenue ($m), USD Constant, 2015-2020 204

Table 115: Clinical Chemistry Analyzers Market, Australia, Revenue ($m), USD Constant, 2021-2025 204

Table 116: Hematology Analyzers Market, Australia, Revenue ($m), USD Constant, 2015-2020 206

Table 117: Hematology Analyzers Market, Australia, Revenue ($m), USD Constant, 2021-2025 207

Table 118: Immunochemistry Analyzers Market, Australia, Revenue ($m), USD Constant, 2015-2020 209

Table 119: Immunochemistry Analyzers Market, Australia, Revenue ($m), USD Constant, 2021-2025 210

Table 120: Polymerase Chain Reaction (PCR) Systems Market, Australia, Revenue ($m), USD Constant, 2015-2020 212

Table 121: Polymerase Chain Reaction (PCR) Systems Market, Australia, Revenue ($m), USD Constant, 2021-2025 213

Table 122: IVD Analyzers and Reagents Market, Australia, Volume (Units), 2015-2020 215

Table 123: IVD Analyzers and Reagents Market, Australia, Volume (Units), 2021-2025 216

Table 124: Clinical Chemistry Analyzers Market, Australia, Volume (Units), 2015-2020 218

Table 125: Clinical Chemistry Analyzers Market, Australia, Volume (Units), 2021-2025 218

Table 126: Hematology Analyzers Market, Australia, Volume (Units), 2015-2020 220

Table 127: Hematology Analyzers Market, Australia, Volume (Units), 2021-2025 221

Table 128: Immunochemistry Analyzers Market, Australia, Volume (Units), 2015-2020 223

Table 129: Immunochemistry Analyzers Market, Australia, Volume (Units), 2021-2025 224

Table 130: Polymerase Chain Reaction (PCR) Systems Market, Australia, Volume (Units), 2015-2020 226

Table 131: Polymerase Chain Reaction (PCR) Systems Market, Australia, Volume (Units), 2021-2025 227

Table 132: IVD Analyzers and Reagents Market, Australia, Average Price ($), 2015-2020 228

Table 133: IVD Analyzers and Reagents Market, Australia, Average Price ($), 2021-2025 230

Table 134: IVD Analyzers and Reagents Market, Australia, Distribution Share by Revenue ($m), USD Constant, 2018 232

Table 135: IVD Analyzers and Reagents Market, Australia, Company Share by Revenue ($m), USD Constant, 2018 234

Table 136: Metabolic Disorder Market, Australia, Revenue ($m), USD Constant, 2015-2020 236

Table 137: Metabolic Disorder Market, Australia, Revenue ($m), USD Constant, 2021-2025 236

Table 138: Diabetes Assays Market, Australia, Revenue ($m), USD Constant, 2015-2020 238

Table 139: Diabetes Assays Market, Australia, Revenue ($m), USD Constant, 2021-2025 239

Table 140: Metabolic Disorder Market, Australia, Volume (Units), 2015-2020 241

Table 141: Metabolic Disorder Market, Australia, Volume (Units), 2021-2025 241

Table 142: Diabetes Assays Market, Australia, Volume (Units), 2015-2020 243

Table 143: Diabetes Assays Market, Australia, Volume (Units), 2021-2025 244

Table 144: Metabolic Disorder Market, Australia, Average Price ($), 2015-2020 245

Table 145: Metabolic Disorder Market, Australia, Average Price ($), 2021-2025 245

Table 146: Metabolic Disorder Market, Australia, Distribution Share by Revenue ($m), USD Constant, 2018 246

Table 147: Metabolic Disorder Market, Australia, Company Share by Revenue ($m), USD Constant, 2018 248

Table 148: Oncology Market, Australia, Segment Contribution (%), 2018 251

Table 149: Oncology Market, Australia, Revenue ($m), USD Constant, 2015-2020 253

Table 150: Oncology Market, Australia, Revenue ($m), USD Constant, 2021-2025 254

Table 151: ALK Tests Market, Australia, Revenue ($m), USD Constant, 2015-2020 256

Table 152: ALK Tests Market, Australia, Revenue ($m), USD Constant, 2021-2025 256

Table 153: BRCA Tests Market, Australia, Revenue ($m), USD Constant, 2015-2020 258

Table 154: BRCA Tests Market, Australia, Revenue ($m), USD Constant, 2021-2025 258

Table 155: Colorectal Cancer Screening Tests Market, Australia, Revenue ($m), USD Constant, 2015-2020 260

Table 156: Colorectal Cancer Screening Tests Market, Australia, Revenue ($m), USD Constant, 2021-2025 260

Table 157: EGFR Tests Market, Australia, Revenue ($m), USD Constant, 2015-2020 262

Table 158: EGFR Tests Market, Australia, Revenue ($m), USD Constant, 2021-2025 263

Table 159: HER2 Amplification Tests Market, Australia, Revenue ($m), USD Constant, 2015-2020 265

Table 160: HER2 Amplification Tests Market, Australia, Revenue ($m), USD Constant, 2021-2025 265

Table 161: KRAS Tests Market, Australia, Revenue ($m), USD Constant, 2015-2020 267

Table 162: KRAS Tests Market, Australia, Revenue ($m), USD Constant, 2021-2025 267

Table 163: Oncology Market, Australia, Volume (Units), 2015-2020 269

Table 164: Oncology Market, Australia, Volume (Units), 2021-2025 270

Table 165: ALK Tests Market, Australia, Volume (Units), 2015-2020 272

Table 166: ALK Tests Market, Australia, Volume (Units), 2021-2025 272

Table 167: BRCA Tests Market, Australia, Volume (Units), 2015-2020 274

Table 168: BRCA Tests Market, Australia, Volume (Units), 2021-2025 274

Table 169: Colorectal Cancer Screening Tests Market, Australia, Volume (Units), 2015-2020 276

Table 170: Colorectal Cancer Screening Tests Market, Australia, Volume (Units), 2021-2025 276

Table 171: EGFR Tests Market, Australia, Volume (Units), 2015-2020 278

Table 172: EGFR Tests Market, Australia, Volume (Units), 2021-2025 279

Table 173: HER2 Amplification Tests Market, Australia, Volume (Units), 2015-2020 281

Table 174: HER2 Amplification Tests Market, Australia, Volume (Units), 2021-2025 281

Table 175: KRAS Tests Market, Australia, Volume (Units), 2015-2020 283

Table 176: KRAS Tests Market, Australia, Volume (Units), 2021-2025 283

Table 177: Oncology Market, Australia, Average Price ($), 2015-2020 284

Table 178: Oncology Market, Australia, Average Price ($), 2021-2025 286

Table 179: Oncology Market, Australia, Distribution Share by Revenue ($m), USD Constant, 2018 288

Table 180: Oncology Market, Australia, Company Share by Revenue ($m), USD Constant, 2018 290

Table 181: Women's Health Market, Australia, Segment Contribution (%), 2018 292

Table 182: Women's Health Market, Australia, Revenue ($m), USD Constant, 2015-2020 294

Table 183: Women's Health Market, Australia, Revenue ($m), USD Constant, 2021-2025 294

Table 184: Prenatal Screening Market, Australia, Revenue ($m), USD Constant, 2015-2020 296

Table 185: Prenatal Screening Market, Australia, Revenue ($m), USD Constant, 2021-2025 297

Table 186: Reproductive Hormones and Proteins Tests Market, Australia, Revenue ($m), USD Constant, 2015-2020 299

Table 187: Reproductive Hormones and Proteins Tests Market, Australia, Revenue ($m), USD Constant, 2021-2025 300

Table 188: Women's Health Market, Australia, Volume (Units), 2015-2020 302

Table 189: Women's Health Market, Australia, Volume (Units), 2021-2025 302

Table 190: Prenatal Screening Market, Australia, Volume (Units), 2015-2020 304

Table 191: Prenatal Screening Market, Australia, Volume (Units), 2021-2025 305

Table 192: Reproductive Hormones and Proteins Tests Market, Australia, Volume (Units), 2015-2020 307

Table 193: Reproductive Hormones and Proteins Tests Market, Australia, Volume (Units), 2021-2025 308

Table 194: Women's Health Market, Australia, Average Price ($), 2015-2020 309

Table 195: Women's Health Market, Australia, Average Price ($), 2021-2025 311

Table 196: Women's Health Market, Australia, Distribution Share by Revenue ($m), USD Constant, 2018 313

Table 197: Women's Health Market, Australia, Company Share by Revenue ($m), USD Constant, 2018 315

Table 198: In Vitro Diagnostics Market Pipeline Products 320

Table 199: Abcam Acquires Expedeon, Innova Biosciences and TGR BioSciences from Expedeon for USD132.2 Million 324

Table 200: SCHOTT to Acquire MINIFAB 327

Table 201: Sonic Healthcare Prices Private Placement of Notes for USD300 Million Due 2030 328

Table 202: Sonic Healthcare Prices Private Placement of Notes for USD150 Million Due 2032 329

Table 203: Sonic Healthcare Prices Private Placement of Notes for USD100 Million Due 2035 330

Table 204: Sienna Cancer Diagnostics Raises USD0.17 Million in Rights Offering of Shares 331

Table 205: Sienna Cancer Diagnostics Raises USD1.1 Million in Private Placement of Shares 333

Table 206: Proteomics International to Raise USD2 Million in Private Placement of Shares 335

Table 207: Total Brain to Raise USD9.6 Million in Private Placement of Shares 336

Table 208: Imagion Biosystems to Raise USD2.5 Million in Rights Offering of Shares 338

Table 209: Genetic Signatures Raises USD1.7 Million in Share Purchase Plan 339

Table 210: Genetic Signatures to Raise USD13.4 Million in Second Tranche of Private Placement of Shares 340

Table 211: Genetic Signatures Raises USD10.4 Million in First Tranche of Private Placement of Shares 342

Table 212: Cellmid Raises USD1.01 Million in Private Placement of Ordinary Shares 344

Table 213: Genetic Technologies to Raise up to USD3 Million in Rights Offering of Shares 345

Table 214: Benitec Biopharma to Raise USD2.25 Million in Private Placement of ADS 347

Table 215: Medibio Raises USD0.8 Million in Share Purchase Plan 349

Table 216: Medibio Raises USD0.2 Million in First Tranche of Private Placement of Shares 351

Table 217: BARD1 Life Sciences Raises USD3.4 Million in Private Placement of Shares 353

Table 218: BARD1 Life Sciences to Raise USD1.7 Million in Rights Offering of Shares 355

Table 219: Microba to Raise USD3 Million in Private Placement of Shares 357

Table 220: Genetic Technologies Raises USD1.2 Million in Private Placement of ADS 358

Table 221: Anteo Diagnostics Raises USD1.79 Million in Rights Offering 359

Table 222: Ellume Plans to Raise Funds in IPO of Shares 360

Table 223: Memphasys Raises USD2.6 Million in Rights Offering of Shares 361

Table 224: QuantuMDx and SpeeDx Enter into Agreement with Foundation for Innovative New Diagnostics (FIND) 362

Table 225: Pillar Biosciences Enters into Co-Marketing Agreement with MGI Tech 363

Table 226: Minomic International and Sienna Cancer Diagnostics Enter into Research Agreement 364

Table 227: Telix Pharma Enters into Licensing Agreement with AusHealth 365

Table 228: Volpara Solutions Enters into Distribution Agreement with ScreenPoint Medical 366

Table 229: ESN Cleer Raises USD0.7 Milllion in Series A Financing 367

Table 230: SpeeDx Raises USD10 Million in Venture Financing 368

Table 231: Ellume Raises USD3.4 Million in Financing Round 369

Table 232: SpeeDx Raises Additional USD5 Million in Series A Financing 370

Table 233: Total Number of Primary Research Participants, In Vitro Diagnostics Market, by Country 476

Figures

1.2 List of Figures

Figure 1: In Vitro Diagnostics Market, Australia, Revenue ($m), USD Constant, 2015-2025 47

Figure 2: In Vitro Diagnostics Market, Australia, Revenue Mix ($m), 2018 49

Figure 3: In Vitro Diagnostics Market, Australia, Category Contribution (%), 2018 50

Figure 4: In Vitro Diagnostics Market, Australia, Revenue ($m), USD Constant, Historic, 2015-2025 52

Figure 5: In Vitro Diagnostics Market, Australia, Volume (Units), 2015-2025 55

Figure 6: In Vitro Diagnostics Market, Australia, Volume (Units), Historic, 2015-2025 57

Figure 7: In Vitro Diagnostics Market, Australia, Company Share (%) 2018 60

Figure 8: Cardiac Disease Market, Australia, Revenue ($m), USD Constant, 2015-2025 62

Figure 9: Cardiac Marker Tests Market, Australia, Revenue ($m), USD Constant, 2015-2025 64

Figure 10: Cardiac Disease Market, Australia, Volume (Units), 2015-2025 67

Figure 11: Cardiac Marker Tests Market, Australia, Volume (Units), 2015-2025 69

Figure 12: Cardiac Disease Market, Australia, Company Share (%) 2018 75

Figure 13: Clinical Chemistry Market, Australia, Revenue ($m), USD Constant, 2015-2025 77

Figure 14: Substrates Market, Australia, Revenue ($m), USD Constant, 2015-2025 79

Figure 15: Clinical Chemistry Market, Australia, Volume (Units), 2015-2025 82

Figure 16: Substrates Market, Australia, Volume (Units), 2015-2025 84

Figure 17: Clinical Chemistry Market, Australia, Company Share (%) 2018 90

Figure 18: Hematological Disorders Market, Australia, Revenue Mix ($m), 2018 91

Figure 19: Hematological Disorders Market, Australia, Segment Contribution (%), 2018 92

Figure 20: Hematological Disorders Market, Australia, Revenue ($m), USD Constant, 2015-2025 93

Figure 21: Hematology Tests Market, Australia, Revenue ($m), USD Constant, 2015-2025 95

Figure 22: Hemostasis Tests Market, Australia, Revenue ($m), USD Constant, 2015-2025 98

Figure 23: Hematological Disorders Market, Australia, Volume (Units), 2015-2025 101

Figure 24: Hematology Tests Market, Australia, Volume (Units), 2015-2025 103

Figure 25: Hemostasis Tests Market, Australia, Volume (Units), 2015-2025 106

Figure 26: Hematological Disorders Market, Australia, Company Share (%) 2018 114

Figure 27: Hormonal Disorders Market, Australia, Revenue ($m), USD Constant, 2015-2025 116

Figure 28: Thyroid Function Tests Market, Australia, Revenue ($m), USD Constant, 2015-2025 118

Figure 29: Hormonal Disorders Market, Australia, Volume (Units), 2015-2025 121

Figure 30: Thyroid Function Tests Market, Australia, Volume (Units), 2015-2025 123

Figure 31: Hormonal Disorders Market, Australia, Company Share (%) 2018 129

Figure 32: Infectious Disease Market, Australia, Revenue Mix ($m), 2018 131

Figure 33: Infectious Disease Market, Australia, Segment Contribution (%), 2018 132

Figure 34: Infectious Disease Market, Australia, Revenue ($m), USD Constant, 2015-2025 134

Figure 35: Chlamydia Trachomatis Tests Market, Australia, Revenue ($m), USD Constant, 2015-2025 139

Figure 36: Clostridium difficile Tests Market, Australia, Revenue ($m), USD Constant, 2015-2025 141

Figure 37: Cytomegalovirus (CMV) Tests Market, Australia, Revenue ($m), USD Constant, 2015-2025 143

Figure 38: Hepatitis Tests Market, Australia, Revenue ($m), USD Constant, 2015-2025 145

Figure 39: Human Immunodeficiency Virus (HIV) Tests Market, Australia, Revenue ($m), USD Constant, 2015-2025 147

Figure 40: Human Papilloma Virus (HPV) Tests Market, Australia, Revenue ($m), USD Constant, 2015-2025 150

Figure 41: Human T-Lymphotropic Virus (HTLV) Tests Market, Australia, Revenue ($m), USD Constant, 2015-2025 152

Figure 42: Mycobacterium Tuberculosis Tests Market, Australia, Revenue ($m), USD Constant, 2015-2025 154

Figure 43: Neisseria Gonorrhoeae Tests Market, Australia, Revenue ($m), USD Constant, 2015-2025 156

Figure 44: Treponema pallidum Tests Market, Australia, Revenue ($m), USD Constant, 2015-2025 158

Figure 45: Infectious Disease Market, Australia, Volume (Units), 2015-2025 161

Figure 46: Chlamydia Trachomatis Tests Market, Australia, Volume (Units), 2015-2025 166

Figure 47: Clostridium difficile Tests Market, Australia, Volume (Units), 2015-2025 168

Figure 48: Cytomegalovirus (CMV) Tests Market, Australia, Volume (Units), 2015-2025 171

Figure 49: Hepatitis Tests Market, Australia, Volume (Units), 2015-2025 173

Figure 50: Human Immunodeficiency Virus (HIV) Tests Market, Australia, Volume (Units), 2015-2025 175

Figure 51: Human Papilloma Virus (HPV) Tests Market, Australia, Volume (Units), 2015-2025 178

Figure 52: Human T-Lymphotropic Virus (HTLV) Tests Market, Australia, Volume (Units), 2015-2025 180

Figure 53: Mycobacterium Tuberculosis Tests Market, Australia, Volume (Units), 2015-2025 182

Figure 54: Neisseria Gonorrhoeae Tests Market, Australia, Volume (Units), 2015-2025 184

Figure 55: Treponema pallidum Tests Market, Australia, Volume (Units), 2015-2025 186

Figure 56: Infectious Disease Market, Australia, Company Share (%) 2018 196

Figure 57: IVD Analyzers and Reagents Market, Australia, Revenue Mix ($m), 2018 198

Figure 58: IVD Analyzers and Reagents Market, Australia, Segment Contribution (%), 2018 199

Figure 59: IVD Analyzers and Reagents Market, Australia, Revenue ($m), USD Constant, 2015-2025 200

Figure 60: Clinical Chemistry Analyzers Market, Australia, Revenue ($m), USD Constant, 2015-2025 203

Figure 61: Hematology Analyzers Market, Australia, Revenue ($m), USD Constant, 2015-2025 205

Figure 62: Immunochemistry Analyzers Market, Australia, Revenue ($m), USD Constant, 2015-2025 208

Figure 63: Polymerase Chain Reaction (PCR) Systems Market, Australia, Revenue ($m), USD Constant, 2015-2025 211

Figure 64: IVD Analyzers and Reagents Market, Australia, Volume (Units), 2015-2025 214

Figure 65: Clinical Chemistry Analyzers Market, Australia, Volume (Units), 2015-2025 217

Figure 66: Hematology Analyzers Market, Australia, Volume (Units), 2015-2025 219

Figure 67: Immunochemistry Analyzers Market, Australia, Volume (Units), 2015-2025 222

Figure 68: Polymerase Chain Reaction (PCR) Systems Market, Australia, Volume (Units), 2015-2025 225

Figure 69: IVD Analyzers and Reagents Market, Australia, Company Share (%) 2018 233

Figure 70: Metabolic Disorder Market, Australia, Revenue ($m), USD Constant, 2015-2025 235

Figure 71: Diabetes Assays Market, Australia, Revenue ($m), USD Constant, 2015-2025 237

Figure 72: Metabolic Disorder Market, Australia, Volume (Units), 2015-2025 240

Figure 73: Diabetes Assays Market, Australia, Volume (Units), 2015-2025 242

Figure 74: Metabolic Disorder Market, Australia, Company Share (%) 2018 247

Figure 75: Oncology Market, Australia, Revenue Mix ($m), 2018 249

Figure 76: Oncology Market, Australia, Segment Contribution (%), 2018 250

Figure 77: Oncology Market, Australia, Revenue ($m), USD Constant, 2015-2025 252

Figure 78: ALK Tests Market, Australia, Revenue ($m), USD Constant, 2015-2025 255

Figure 79: BRCA Tests Market, Australia, Revenue ($m), USD Constant, 2015-2025 257

Figure 80: Colorectal Cancer Screening Tests Market, Australia, Revenue ($m), USD Constant, 2015-2025 259

Figure 81: EGFR Tests Market, Australia, Revenue ($m), USD Constant, 2015-2025 261

Figure 82: HER2 Amplification Tests Market, Australia, Revenue ($m), USD Constant, 2015-2025 264

Figure 83: KRAS Tests Market, Australia, Revenue ($m), USD Constant, 2015-2025 266

Figure 84: Oncology Market, Australia, Volume (Units), 2015-2025 268

Figure 85: ALK Tests Market, Australia, Volume (Units), 2015-2025 271

Figure 86: BRCA Tests Market, Australia, Volume (Units), 2015-2025 273

Figure 87: Colorectal Cancer Screening Tests Market, Australia, Volume (Units), 2015-2025 275

Figure 88: EGFR Tests Market, Australia, Volume (Units), 2015-2025 277

Figure 89: HER2 Amplification Tests Market, Australia, Volume (Units), 2015-2025 280

Figure 90: KRAS Tests Market, Australia, Volume (Units), 2015-2025 282

Figure 91: Oncology Market, Australia, Company Share (%) 2018 289

Figure 92: Women's Health Market, Australia, Revenue Mix ($m), 2018 291

Figure 93: Women's Health Market, Australia, Segment Contribution (%), 2018 292

Figure 94: Women's Health Market, Australia, Revenue ($m), USD Constant, 2015-2025 293

Figure 95: Prenatal Screening Market, Australia, Revenue ($m), USD Constant, 2015-2025 295

Figure 96: Reproductive Hormones and Proteins Tests Market, Australia, Revenue ($m), USD Constant, 2015-2025 298

Figure 97: Women's Health Market, Australia, Volume (Units), 2015-2025 301

Figure 98: Prenatal Screening Market, Australia, Volume (Units), 2015-2025 303

Figure 99: Reproductive Hormones and Proteins Tests Market, Australia, Volume (Units), 2015-2025 306

Figure 100: Women's Health Market, Australia, Company Share (%) 2018 314

Frequently asked questions

Australia In Vitro Diagnostics Market Outlook to 2025 – Cardiac Disease, Clinical Chemistry, Hematological Disorders and Others. standard reports
Currency USD
$5,995

Can be used by individual purchaser only

Most Popular
$11,990

Can be shared by unlimited users within one corporate location e.g. a regional office

$17,985

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Add to Basket

Undecided about purchasing this report?

Enquire Before Buying

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

 Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

 Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

 Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

 Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

 Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

 Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

 Senior Account Manager, TSYS

Related reports

View more In Vitro Diagnostics reports
Medical Devices
New
PTA Peripheral DCB Catheters Pipeline by Development Stages, Segments, Region…
$4,000 | March 2024
Medical Devices
New
PCR Systems Market Size by Segments, Share, Regulatory, Reimbursement, Installed…
$7,500 | March 2024
Medical Devices
New
Immunochemistry Analyzers Market Size by Segments, Share, Regulatory, Reimbursement, Installed…
$7,500 | March 2024
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Australia In Vitro Diagnostics Market Outlook to 2025 – Cardiac Disease, Clinical Chemistry, Hematological Disorders and Others. in real time.

  • Access a live Australia In Vitro Diagnostics Market Outlook to 2025 – Cardiac Disease, Clinical Chemistry, Hematological Disorders and Others. dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.
Tell me more